We recently compiled a list of the 20 Best Biotech Stocks Under $20 to Buy Now. MiMedx Group, Inc. (NASDAQ:MDXG) is on our list of best biotech stocks. TheFly reported on January 23 that Craig-Hallum analyst Chase Knickerbocker lowered the price target on MDXG to $10 from $13 and maintained a Buy rating. The revision followed recent CMS guidance on provider billing and the withdrawal of the local coverage determination, which the firm expects to create provider confusion and pressure wound care volumes in ...

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on October 9, 2025. TURN THERAPEUTICS INC. (Exact Name of Registrant as Specified in Its Charter) Delaware (State or Other Jurisdiction of Incorporation or Organization) 2834 (Primary Standard Industrial Classification Code Number) 32-0456090 (I.R.S. Employer 250 N. Westlake Blvd. Westlake Village, CA 91362 (818) 564-4011 (Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant's Principal Executive Offices) ...

TABLE OF CONTENTS As filed with the Securities and Exchange Commission on September 16, 2025 Registration No. 333-289972 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Amendment No. 1 to FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 GLOBAL HEALTH SOLUTIONS, INC. (Exact Name of Registrant as Specified in Its Charter) † 2834 (Primary Standard Industrial Delaware (State or Other Jurisdiction of Incorporation or Organization) 32-0456090 (I.R.S. Employer Identification ...

Market Overview - The S&P 500 index declined by 0.4%, marking its second drop in three trading days, primarily due to weakness in financial stocks [1] - The index briefly surpassed the significant 6300 level before falling, while the Nasdaq 100 index rose by 0.1%, reaching a new closing record [1] - All but one of the 24 stocks in the KBW Bank Index fell, with Citigroup being the exception, which rose by 3.7% due to strong trading performance [1] Financial Sector Performance - Wells Fargo's stock dropped by 5.5% after it lowered its full-year net interest income forecast [1] - BlackRock's stock fell by 5.9% as its second-quarter net inflows missed analyst expectations [1] - JPMorgan Chase's stock decreased by 0.7%, despite a slight increase in investment banking revenue [1] Economic Indicators - The CPI inflation data showed a moderate increase, with core CPI rising by 0.2% month-over-month in June, below the expected 0.3% [5] - Analysts expect a modest 2.5% year-over-year profit growth for the S&P 500 in the second quarter, down from 9.4% in early April [2] Notable Company Movements - Nvidia's stock increased by 4% as the company plans to resume sales of its H20 AI chips in China after receiving assurances from Washington [5] - Apple Inc. shares rose by 0.2% following a $500 million agreement to purchase rare earth minerals from MP Materials [6] - Trade Desk's stock surged by 6.6% after being announced as a new addition to the S&P 500 index [7] Sector Trends - Ten out of eleven sectors in the S&P 500 saw declines, with financial, materials, and healthcare sectors leading the losses, while technology stocks gained [1] - The Philadelphia Semiconductor Index rose by 1.3%, reflecting positive sentiment in the semiconductor sector alongside Nvidia's performance [5]

Group 1 - U.S. stock futures are higher, with Nasdaq futures gaining approximately 100 points [1] - Simulations Plus, Inc. reported quarterly earnings of 45 cents per share, exceeding the analyst consensus estimate of 7 cents per share [2] - Simulations Plus reported quarterly sales of $20.363 million, which fell short of the analyst consensus estimate of $20.878 million [2] - Keybanc analyst downgraded Simulations Plus from Overweight to Sector Weight, leading to a 6.3% dip in shares to $16.37 in pre-market trading [2] Group 2 - Presidio Property Trust, Inc. shares fell 29.9% to $9.55 after a significant 166% increase on Monday, following a $2.05 million registered direct offering [4] - MiNK Therapeutics, Inc. shares declined 27.5% to $29.45 after a 37% drop on Monday, with an analyst downgrade from Outperform to Market Perform [4] - Organogenesis Holdings Inc. shares dropped 26.7% to $3.29 after gaining over 4% on Monday [4] - MiMedx Group, Inc. shares fell 20.7% to $5.38 in pre-market trading [4] - Sequans Communications S.A. shares declined 10.8% to $5.01 after a 20% increase on Monday due to Bitcoin acquisition news [4] - Iovance Biotherapeutics, Inc. shares decreased 5.5% to $1.8990 in pre-market trading [4] - FB Financial Corporation shares fell 5.4% to $46.50 following disappointing quarterly sales [4] - ProKidney Corp. shares dropped 4.6% to $3.52 after filing for a common stock offering of up to $200 million [4] - Blue Gold Limited shares declined 4.5% to $26.60 after a 30% surge on Monday [4]

Company Announcement - MiMedx Group, Inc. will report its operating and financial results for Q1 2025 on April 30, 2025, after market close [1] - A webcast and conference call will be held at 4:30 p.m. Eastern Time on the same day to review the results [1] - The conference call can be accessed by U.S. investors at 877-407-6184 and international investors at 201-389-0877, with a conference ID of 13752696 [1] Company Overview - MiMedx is a pioneer and leader in healing solutions, focusing on chronic and hard-to-heal wounds [2] - The company aims to provide a leading portfolio of products for wound care, burn, and surgical sectors [2] - MiMedx's vision is to be the leading global provider of healing solutions through relentless innovation [2]

Core Insights - MiMedx Group, Inc. will participate in several industry conferences this quarter to showcase its Advanced Wound Care and Surgical Solutions [1][2] - The company aims to highlight its commitment to innovation and the scientific evidence supporting its products at these conferences [2] Conference Participation - MiMedx will be featured at the Diabetic Limb Salvage (DLS) Conference from April 10-12, 2025, in Washington, D.C., where it will host a sponsored lunch symposium [3] - The company will also participate in the Symposium on Advanced Wound Care (SAWC) Spring 2025 from April 30 to May 4, 2025, in Grapevine, TX, with another sponsored lunch symposium [3] - Additionally, MiMedx will present at Digestive Disease Week (DDW) 2025 from May 3-6, 2025, in San Diego, CA, focusing on the use of amniotic tissues in colorectal surgery [4] Company Overview - MiMedx is recognized as a leader in providing solutions for chronic and hard-to-heal wounds, with a vision to be the leading global provider of healing solutions through innovation [4] - The company has over a decade of experience in the wound care, burn, and surgical sectors of healthcare [4] Conference Details - The DLS Conference emphasizes a multidisciplinary approach to wound healing and limb salvage, featuring an international faculty and promoting evidence-based practices [5] - The SAWC serves as a forum for the entire wound care team to connect and improve patient outcomes through education and advanced clinical reviews [6] - DDW is the largest international gathering in gastroenterology and related fields, showcasing over 4,400 abstracts and hundreds of lectures on the latest advances [7]